13 Dec SAHPRA’s position on Semaglutide compounded products
Pretoria, 13 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) recently released a media statement on the falsified Ozempic products currently being sold on the market and online, specifically unauthorised Ozempic/semaglutide-containing products. SAHPRA has registered one product which contains semaglutide called Ozempic. There...
